Past, present and future perspectives in nonalcoholic fatty liver disease

被引:358
|
作者
Sanyal, Arun J. [1 ]
机构
[1] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Sch Med, Richmond, VA 23284 USA
关键词
UNFOLDED PROTEIN RESPONSE; TOLL-LIKE RECEPTORS; LONG-TERM OUTCOMES; UNITED-STATES; VITAMIN-E; INSULIN-RESISTANCE; HEPATIC STEATOSIS; FIBROSIS STAGE; HEPATOCELLULAR-CARCINOMA; TRANSIENT ELASTOGRAPHY;
D O I
10.1038/s41575-019-0144-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) was first described as a distinct clinical entity four decades ago. However, the condition has become the centre of attention within hepatology owing to its high prevalence and growing contribution to the burden of end-stage liver disease in the general population. This Perspective provides an overview on the development of knowledge related to NAFLD with a focus on landmark findings that have influenced current paradigms and key knowledge gaps that need to be filled to make progress. Specifically, a timeline of scientific discovery of both basic disease mechanisms (with a focus on human data) and the evolution of knowledge about the clinical course of the disease is provided and related to current approaches to treat and eventually prevent NAFLD.
引用
收藏
页码:377 / 386
页数:10
相关论文
共 50 条
  • [1] Past, present and future perspectives in nonalcoholic fatty liver disease
    Arun J. Sanyal
    [J]. Nature Reviews Gastroenterology & Hepatology, 2019, 16 : 377 - 386
  • [2] Molecular Signatures of Nonalcoholic Fatty Liver Disease: The Present and Future
    Yilmaz, Yusuf
    Ulukaya, Engin
    [J]. HEPATOLOGY, 2010, 51 (05) : 1866 - 1866
  • [3] Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery
    Domingues, Ines
    Leclercq, Isabelle A.
    Beloqui, Ana
    [J]. JOURNAL OF CONTROLLED RELEASE, 2023, 363 : 415 - 434
  • [4] Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Younossi, Zobair
    Tacke, Frank
    Arrese, Marco
    Sharma, Barjesh Chander
    Mostafa, Ibrahim
    Bugianesi, Elisabetta
    Wong, Vincent Wai-Sun
    Yilmaz, Yusuf
    George, Jacob
    Fan, Jiangao
    Vos, Miriam B.
    [J]. HEPATOLOGY, 2019, 69 (06) : 2672 - 2682
  • [5] The Future of Nonalcoholic Fatty Liver Disease Treatment
    Mazhar, Khurram
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (01) : 57 - +
  • [6] Nonalcoholic fatty liver disease in Asia: emerging perspectives
    Seto, Wai-Kay
    Yuen, Man-Fung
    [J]. JOURNAL OF GASTROENTEROLOGY, 2017, 52 (02) : 164 - 174
  • [7] Obesity and nonalcoholic fatty liver disease: current perspectives
    Sarwar, Raiya
    Pierce, Nicholas
    Koppe, Sean
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2018, 11 : 533 - 542
  • [8] Nonalcoholic fatty liver disease in Asia: emerging perspectives
    Wai-Kay Seto
    Man-Fung Yuen
    [J]. Journal of Gastroenterology, 2017, 52 : 164 - 174
  • [9] Nutrition and Nonalcoholic Fatty Liver Disease Current Perspectives
    Chakravarthy, Manu, V
    Waddell, Thomas
    Banerjee, Rajarshi
    Guess, Nicola
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2020, 49 (01) : 63 - +
  • [10] Statins and nonalcoholic fatty liver disease: a bright future?
    Athyros, Vasilios G.
    Katsiki, Niki
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (09) : 1089 - 1093